Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

People On The Move: Appointments At Maxwellia, Reckitt, Barentz

A round-up of the latest European consumer health appointments: Maxwellia adds CFO and board member; Reckitt restructures operations; Barentz names CEO.

Haleon Completes Deal To Grow Stake In China JV

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

People On The Move: Appointments At Boiron, Dr. Theiss, ProBiotix

A round-up of the latest European consumer health industry appointments: Boiron hires former Henkel exec as CEO; Dr. Theiss Naturwaren names managing director; ProBiotix Health adds scientific expertise.

UK Finds Turmeric Supplements Pose Risk To Health

UK food toxicity committee says substantial exceedances of the Acceptable Daily Intake of turmeric - such as through excessive supplement use - represents a potential health risk to humans.

France Reverse-Switches Pseudoephedrine OTCs Over Long-Running Safety Concerns

Oral pseudoephedrine decongestants marketed by Kenuve, Haleon and Opella, amongst others, are now only available with a doctor's prescription in France.

People On The Move: Appointments at CHP Australia, Opella, Ascendis

Round-up of the latest people moves: CHP Australia names new chief exec; Opella appoints Vietnam head; Ascendis makes permanent CFO appointment.